Subdividing ART patients and analyzing the medical burden by modeling of CD4 cell count
- PMID: 37091020
- PMCID: PMC10114561
- DOI: 10.4103/jfmpc.jfmpc_1765_22
Subdividing ART patients and analyzing the medical burden by modeling of CD4 cell count
Abstract
Objective: To subdivide the antiretroviral therapy (ART) human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) patients by modeling the CD4 cell count variable, with an aim to reduce the medical burden from lifelong ART.
Materials and methods: The data of outpatients at the research unit between August 2009 and December 2020 were exported and mined. A recency-frequency (RF) model was established for data subdivision, and data of non-churn ART patients were preserved. Common factor analysis (CFA) was conducted on the three indicators of the baseline/mean/last CD4 cell counts to obtain critical variables; then, k-means modeling was used to subdivide ART patients and their medical burden was analyzed.
Results: A total of 12,106 samples of non-churn ART patients were preserved by RF modeling. The baseline/mean/last CD4 cell counts served as important variables employed for modeling. The patients were divided into 15 types, including two types with poor compliance and poor immune reconstitution, two types with good compliance but poor immune reconstitution, four types with poor compliance but good immune reconstitution, and seven types with good compliance and good immune reconstitution. The frequency of visits was 5.25-9.95 visits/person/year, and the percentage of examination fees was 44.24%-59.05%, with a medical burden of 4114.24-12,676.66 yuan/person/year, of which 42.62%-70.09% was reduced.
Conclusion: The CD4 cell count is not only an important indicator for judging post-ART immune recovery, but also a major modeling variable in subdividing ART patients with varying medical burdens. Poor compliance and poor immune reconstitution lead to excessive visits and frequent examinations, which were the leading causes of the heavy medical burden of ART.
Keywords: Antiretroviral therapy; CD4 cell count; common factor analysis; data mining; medical burden; recency-frequency model.
Copyright: © 2023 Journal of Family Medicine and Primary Care.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.J Infect Public Health. 2018 Mar-Apr;11(2):265-269. doi: 10.1016/j.jiph.2017.08.001. Epub 2017 Aug 18. J Infect Public Health. 2018. PMID: 28826735
-
Survival, CD4 T lymphocyte count recovery and immune reconstitution pattern during the first-line combination antiretroviral therapy in patients with HIV-1 infection in Mongolia.PLoS One. 2021 Mar 8;16(3):e0247929. doi: 10.1371/journal.pone.0247929. eCollection 2021. PLoS One. 2021. PMID: 33684169 Free PMC article.
-
Suboptimal immune recovery and associated factors among people living with HIV/AIDS on second-line antiretroviral therapy in central China: A retrospective cohort study.J Med Virol. 2022 Oct;94(10):4975-4982. doi: 10.1002/jmv.27944. Epub 2022 Jul 10. J Med Virol. 2022. PMID: 35710693
-
Association of CD4 T cell count and optimal timing of antiretroviral therapy initiation with immune reconstitution inflammatory syndrome and all-cause mortality for HIV-infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta-analysis.Int J Clin Exp Pathol. 2021 Jun 15;14(6):670-679. eCollection 2021. Int J Clin Exp Pathol. 2021. PMID: 34239668 Free PMC article. Review.
-
Alterations in circulating markers in HIV/AIDS patients with poor immune reconstitution: Novel insights from microbial translocation and innate immunity.Front Immunol. 2022 Oct 17;13:1026070. doi: 10.3389/fimmu.2022.1026070. eCollection 2022. Front Immunol. 2022. PMID: 36325329 Free PMC article. Review.
References
-
- Alvi Y, Faizi N, Khalique N, Ahmad A. Assessment of out-of-pocket and catastrophic expenses incurred by patients with Human Immunodeficiency Virus (HIV) in availing free antiretroviral therapy services in India. Public Health. 2020;183:16–22. - PubMed
-
- Toh HS, Yang CT, Yang KL, Ku HC, Liao CT, Kuo S, et al. Reduced economic burden of AIDS-defining illnesses associated with adherence to antiretroviral therapy. Int J Infect Dis. 2020;91:44–9. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials